U.S. market Closed. Opens in 4 hours

TXG | 10x Genomics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue618.73M516.41M490.49M298.85M245.89M146.31M71.08M
Cost of Revenue209.41M120.39M74.09M58.47M61.03M28.66M10.56M
Gross Profit409.31M396.02M416.40M240.38M184.86M117.65M60.52M
Operating Expenses611.18M563.97M469.31M325.70M213.93M135.47M78.90M
Selling, General & Admin340.85M298.30M257.56M202.33M130.83M87.94MN/A
Research & Development270.33M265.67M211.75M123.38M83.10M47.54M32.16M
Other Operating Expenses-307.00K-198.00K-802.00K1.34M-186.00K-249.00K46.74M
Operating Income-201.87M-167.94M-52.91M-85.32M-29.07M-110.76M-18.38M
Other Expenses / Income-46.90M5.97M-802.00K-449.15M-1.96M-93.19M-366.00K
Before Tax Income-248.76M-161.97M-53.72M-534.48M-31.03M-112.40M-18.74M
Income Tax Expenses6.34M4.03M4.51M8.26M218.00K87.00K21.00K
Net Income-255.10M-166.00M-58.22M-542.73M-31.25M-112.48M-18.76M
Interest Expenses33.00K476.00K866.00K1.68M3.08M2.41M811.00K
Basic Shares Outstanding117.17M113.86M110.35M101.15M39.06M82.89M82.89M
Diluted Shares Outstanding117.17M113.86M110.35M101.15M39.09M82.89M82.89M
EBITDA-158.25M-161.50M-53.51M-82.45M-26.45M-13.14M-13.62M
EBITDA Margin-25.58%-31.27%-10.91%-27.59%-10.76%-8.98%-19.17%
EBIT-248.73M-161.50M-52.85M-532.79M-27.95M-109.99M-17.93M
EBIT Margin-40.20%-31.27%-10.77%-178.28%-11.37%-75.17%-25.22%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙